Asthma Therapies Now Approved for Pediatric Patients
The FDA has approved updated labeling for Asmanex HFA and Dulera to include use in pediatric patients with asthma.
News
LATEST NEWS
Efficacy of Acellular Pertussis Vaccine Over Time
Undervaccinated and especially unvaccinated children were at greater risk for pertussis.
Cancer Survivors With High-Deductible Health Plans More Likely to Experience Delayed Care
Having a health savings account can mitigate the effect of a high-deductible health plan.
Treatment Adherence in Adults With Asthma and COPD
In Europe, researchers conducted a study to determine whether adult patients with asthma and chronic obstructive pulmonary disease who use the budesonide/formoterol inhaler are very satisfied.
Effects of a Video Intervention on Asthma Control in Adolescents
An interventional video and question prompt list were not associated with improvements in asthma control and quality of life, according to a study recently published in the Journal of Asthma. Researchers of this study observed 359 patients aged 11 to 17 years with persistent asthma, 91.3% of whom spoke English at home instead of Spanish. These…
Health-Related Quality of Life in Patients With Asthma and Allergies
The presence of persistent asthma and comorbid allergies has been linked to a significant adverse impact of certain measures of health-related quality of life (HRQoL). A retrospective analysis was conducted of patient survey responses and administrative pharmacy claims from the Observational Study of Asthma Control and Outcomes (OSACO), and the results were published in the…
Jobs With Higher COPD Risk Prompt Need for Preventive Strategies
Several occupational categories increased the risk for chronic obstructive pulmonary disease in nonsmoking/nonasthmatic individuals.
Bedaquiline Approved to Treat Adolescent Patients With Multidrug-Resistant TB
The FDA has approved Sirturo (bedaquiline; Janssen) for use in pediatric patients aged 12 to less than 18 years in MDR-TB.
UPCOMING MEETINGS
FEBRUARY 22-25
American Academy of Allergy, Asthma and Immunology (AAAAI) 2019 Annual Meeting
San Francisco, CA
February 27-28
5th International Conference on Respiratory and Pulmonary Medicine
Paris, France
April 10-13
ELCC 2019: European Lung Cancer Conference
Geneva, Switzerland
DRUG NEWS FROM MPR
Molgramostim Misses Primary End Point in Alveolar Pulmonary Proteinosis Trial
CDC Announces Number of Expired Flu Vaccines Administered Last Season
Sildenafil for Oral Suspension Available to Treat Pulmonary Arterial Hypertension
Glass Fragment Prompts Recall of Immunosuppressive Agent
Inhaled Molgramostim Granted Fast Track Status for Autoimmune Pulmonary Alveolar Proteinosis
Aclidinium Bromide and Formoterol Fumarate Approved for COPD Maintenance Treatment
Recombinant Human Pentraxin-2 Gets Breakthrough Tx Designation for Idiopathic Pulmonary Fibrosis
First Generic Version of Treprostinil Available for PAH
Does Elderberry Supplementation Reduce Upper Respiratory Symptoms?
Dupilumab Approved to Treat Adolescents With Moderate-to-Severe Atopic Dermatitis
Antiviral Agents Compared for Treatment of Influenza
Antiviral Agents Compared for Treatment of Influenza
Prevnar 13 Linked to Reduced Risk of CAP Hospitalization in Older Patients
Trelegy Ellipta Gains Expanded COPD Indication, Loses Boxed Warning
Sinuva Sinus Implant Launched to Treat Recurrent Nasal Polyps
Want to read more?
Please login or register first to view this content.